Is Marijuana the Key to Fewer Opioid Prescriptions?

As the U.S. experiences the most opioid overdoses in history, states that have legalized marijuana report a decline in fills of opioid drug prescriptions. While these two data points may be true, the natural next question of correlation beckons. Could marijuana use among pain patients be the reason, and would an expanded legalization yield extrapolated benefits?

Read more

Alex Azar Sworn In As Trump’s New HHS Secretary

Alex Azar, a former 10-year executive of drug company Eli Lilly & Co., was sworn in as the new Secretary of Health and Human Services (HHS). Azar served as Deputy Secretary of Health and Human Services under President George W. Bush. Supporters of his appointment see him as seasoned on industry matters and an experienced former HHS member. However, detractors challenge his ability to attack the primary issues facing HHS without bias. They note Azar’s significant time in the pharmaceutical industry and highlight former consultancy work at health insurance companies and biopharmaceuticals.

Read more

Vital Facts About Trump Opioid Crisis Emergency Plan

President Trump recently declared the opioid crisis a national public health emergency, ignoring the recommendation of his opioid commission and breaking the promise to sign a national emergency declaration over the summer. Can the U.S. response to this crisis really be funded by $57,000 and taking back money already disbursed for HIV/AIDS treatment and training laid-off workers?

Read more

Forgotten Victims of the Opioid Crisis: Patients in Pain

The opioid crisis grows more deadly by the day, and lawmakers are scrambling to stem the tide. But these actions to stop abuse are creating unintended victims. Patients who legitimately need the drugs to combat debilitating pain are faced with a dizzying array of hoops, and in some cases denied access altogether.

Read more